Annual CFF
-$9.72 M
-$36.88 M-135.81%
31 December 2023
Summary:
Century Therapeutics annual cash flow from financing activities is currently -$9.72 million, with the most recent change of -$36.88 million (-135.81%) on 31 December 2023. During the last 3 years, it has fallen by -$57.41 million (-120.39%). IPSC annual CFF is now -102.33% below its all-time high of $417.77 million, reached on 31 December 2021.IPSC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$273.00 K
-$56.42 M-99.52%
30 September 2024
Summary:
Century Therapeutics quarterly cash flow from financing activities is currently $273.00 thousand, with the most recent change of -$56.42 million (-99.52%) on 30 September 2024. Over the past year, it has dropped by -$27.00 thousand (-9.00%). IPSC quarterly CFF is now -99.88% below its all-time high of $224.65 million, reached on 30 June 2021.IPSC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$74.81 M
-$27.00 K-0.04%
30 September 2024
Summary:
Century Therapeutics TTM cash flow from financing activities is currently $74.81 million, with the most recent change of -$27.00 thousand (-0.04%) on 30 September 2024. Over the past year, it has increased by +$84.08 million (+906.65%). IPSC TTM CFF is now -83.94% below its all-time high of $465.83 million, reached on 30 June 2021.IPSC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -135.8% | -9.0% | +906.6% |
| 3 y3 years | -120.4% | +158.6% | -83.6% |
| 5 y5 years | - | - | - |
IPSC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -102.3% | at low | -99.5% | +102.7% | -83.6% | +869.2% |
| 5 y | 5 years | -102.3% | at low | -99.9% | +102.7% | -83.9% | +869.2% |
| alltime | all time | -102.3% | at low | -99.9% | +102.7% | -83.9% | +869.2% |
Century Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $273.00 K(-99.5%) | $74.81 M(-0.0%) |
| June 2024 | - | $56.70 M(+211.6%) | $74.84 M(+832.9%) |
| Mar 2024 | - | $18.20 M(-5211.0%) | $8.02 M(-182.5%) |
| Dec 2023 | -$9.72 M(-135.8%) | -$356.00 K(-218.7%) | -$9.72 M(+4.9%) |
| Sept 2023 | - | $300.00 K(-103.0%) | -$9.27 M(-1.7%) |
| June 2023 | - | -$10.12 M(-2358.3%) | -$9.44 M(-1396.3%) |
| Mar 2023 | - | $448.00 K(+371.6%) | $728.00 K(-97.3%) |
| Dec 2022 | $27.16 M | $95.00 K(-30.7%) | $27.16 M(-0.0%) |
| Sept 2022 | - | $137.00 K(+185.4%) | $27.17 M(+2.3%) |
| June 2022 | - | $48.00 K(-99.8%) | $26.57 M(-89.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $26.88 M(>+9900.0%) | $251.17 M(-39.9%) |
| Dec 2021 | $417.77 M(+776.0%) | $106.00 K(-122.7%) | $417.77 M(-8.3%) |
| Sept 2021 | - | -$466.00 K(-100.2%) | $455.77 M(-2.2%) |
| June 2021 | - | $224.65 M(+16.1%) | $465.83 M(+93.2%) |
| Mar 2021 | - | $193.49 M(+407.8%) | $241.18 M(+405.7%) |
| Dec 2020 | $47.69 M(-36.3%) | $38.10 M(+296.8%) | $47.69 M(+397.3%) |
| Sept 2020 | - | $9.60 M(<-9900.0%) | $9.59 M(<-9900.0%) |
| June 2020 | - | -$11.00 K(<-9900.0%) | -$11.00 K(<-9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $74.84 M | - | - |
FAQ
- What is Century Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Century Therapeutics?
- What is Century Therapeutics annual CFF year-on-year change?
- What is Century Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Century Therapeutics?
- What is Century Therapeutics quarterly CFF year-on-year change?
- What is Century Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Century Therapeutics?
- What is Century Therapeutics TTM CFF year-on-year change?
What is Century Therapeutics annual cash flow from financing activities?
The current annual CFF of IPSC is -$9.72 M
What is the all time high annual CFF for Century Therapeutics?
Century Therapeutics all-time high annual cash flow from financing activities is $417.77 M
What is Century Therapeutics annual CFF year-on-year change?
Over the past year, IPSC annual cash flow from financing activities has changed by -$36.88 M (-135.81%)
What is Century Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of IPSC is $273.00 K
What is the all time high quarterly CFF for Century Therapeutics?
Century Therapeutics all-time high quarterly cash flow from financing activities is $224.65 M
What is Century Therapeutics quarterly CFF year-on-year change?
Over the past year, IPSC quarterly cash flow from financing activities has changed by -$27.00 K (-9.00%)
What is Century Therapeutics TTM cash flow from financing activities?
The current TTM CFF of IPSC is $74.81 M
What is the all time high TTM CFF for Century Therapeutics?
Century Therapeutics all-time high TTM cash flow from financing activities is $465.83 M
What is Century Therapeutics TTM CFF year-on-year change?
Over the past year, IPSC TTM cash flow from financing activities has changed by +$84.08 M (+906.65%)